Hartford Investment Management CO United Therapeutics Corp Transaction History

Hartford Investment Management CO

  • $2.99 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 04, 2020
SELL
$92.74 - $125.82 $629,982 - $854,695
-6,793 Closed
0 $0
Q1 2020

Apr 24, 2020
SELL
$79.39 - $115.35 $99,793 - $144,994
-1,257 Reduced 15.61%
6,793 $644,000
Q3 2019

Oct 28, 2019
BUY
$74.85 - $85.99 $602,542 - $692,219
8,050 New
8,050 $642,000

Others Institutions Holding UTHR

# of Institutions
672
Shares Held
42.4M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email